ARVINAS, INC. (ARVN)

Empfehlung

9,9
Stark Verkaufen
Composite Score (0–100)
Insider (25%)
39.6
1 Insider, 268K $ Volumen
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,72% (Stand: 28.02.2026)

Score-Verlauf (90 Tage)

Stammdaten

Unternehmen

NameARVINAS, INC.
TickerARVN
CIK0001655759

Branche

SIC-Code2834
BeschreibungPharmaceutical Preparations

Wertpapier

CUSIP
ISIN
TypCommon Stock
TitelARVINAS, INC.

Status

Zuletzt geprüft2026-03-20 22:36:39.694274

Fondsaktivität (letzte 3 Quartale)

Keine Fondsdaten für dieses Unternehmen vorhanden.

Insider-Transaktionen (12 Monate)

DatumInsiderRolleTypStückzahlKursWert (USD)ΔTrend
2026-03-06Morrison BriggsDirectorOpen Market Purchase20,00013.40268,070.00+239,2%
2026-02-27Houston John GDirectorOpen Market Sale-18,82213.24-249,203.28-222,4%
2026-02-27Houston John GDirectorOpen Market Sale-4,68813.24-62,069.12-55,4%
2026-02-27Houston John GDirectorOpen Market Sale-11,78713.14-154,881.18-138,2%
2026-02-13Saik AndrewOfficer, Chief Financial OfficerOpen Market Sale-5,13411.89-61,043.26-54,5%
2026-02-13Saik AndrewOfficer, Chief Financial OfficerOpen Market Sale-5,13411.89-61,043.26-54,5%
2025-09-22Morrison BriggsDirectorOpen Market Purchase30,0007.57227,010.00+202,6%
2025-06-24Saik AndrewOfficer, Chief Financial OfficerOpen Market Sale-5,7007.61-43,377.00-38,7%
2025-06-24Saik AndrewOfficer, Chief Financial OfficerOpen Market Sale-5,7007.61-43,377.00-38,7%
2025-06-24Saik AndrewOfficer, Chief Financial OfficerOpen Market Sale-5,7007.61-43,377.00-38,7%
2025-06-17Cacace Angela MOfficer, Chief Scientific OfficerOpen Market Sale-2,5837.49-19,346.67-17,3%

Top-Fondshalter (aktuelles Quartal)

Keine Fondsdaten für das aktuelle Quartal vorhanden.